Toxicodynamics within the realm of biopharmaceutics explores the dynamic interactions between a drug and the body, focusing on the mechanisms that govern toxicity. Understanding toxicodynamics is crucial for assessing how a biopharmaceutical agent behaves within the biological system, influencing its absorption, distribution, metabolism, and excretion.
This facet of biopharmaceutics delves into the specific molecular and physiological responses to a drug, shedding light on potential adverse effects and establishing safe dosage parameters. Factors such as receptor binding, signal transduction pathways, and the overall impact on cellular function are key considerations in toxicodynamic assessments.
Researchers in biopharmaceutics strive to unravel the intricate web of toxicodynamic relationships to enhance drug safety and efficacy. By elucidating the mechanisms behind drug toxicity, the field contributes significantly to the development of pharmaceuticals with minimized adverse effects and optimized therapeutic outcomes. Toxicodynamics thus stands as a vital component in the comprehensive study of biopharmaceutics, ensuring that pharmaceutical interventions are not only effective but also safe for patient use.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico